117810-52-3Relevant articles and documents
QUINOLINE DERIVATIVES AS SMO INHIBITORS
-
Paragraph 0110; 0114, (2017/02/28)
Disclosed are quinoline derivatives as hedgehog pathway inhibitors, especially as SMO inhibitors. Compounds of the present invention can be used in treating diseases relating to hedgehog pathway including cancer.
Composition Comprising An NK-1 Receptor Antagonist And An SSRI For The Treatment Of Tinnitus And Hearing Loss
-
, (2010/12/29)
The present invention relates to methods for treating a subject suffering from tinnitus, hearing loss, or tinnitus and hearing loss comprising administering to the subject an effective amount of an NK1 receptor antagonist alone, or in combination with an
Design, synthesis, and preliminary pharmacological evaluation of 1,4- diazabicyclo[4.3.0]nonan-9-ones as a new class of highly potent nootropic agents
Manetti, Dina,Ghelardini, Carla,Bartolini, Alessandro,Bellucci, Cristina,Dei, Silvia,Galeotti, Nicoletta,Gualtieri, Fulvio,Romanelli, Maria Novella,Scapecchi, Serena,Teodori, Elisabetta
, p. 1969 - 1974 (2007/10/03)
Several 4-substituted 1,4-diazabicyclo[4.3.0]nonan-9-ones have been synthesized and tested in vivo on mouse passive avoidance test, to evaluate their nootropic activity. The results show that they represent a new class of nootropic drugs with a pharmacolo